Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXEMESTANE Cause Multiple organ dysfunction syndrome? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Multiple organ dysfunction syndrome have been filed in association with EXEMESTANE (Exemestane). This represents 0.2% of all adverse event reports for EXEMESTANE.

18
Reports of Multiple organ dysfunction syndrome with EXEMESTANE
0.2%
of all EXEMESTANE reports
18
Deaths
11
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From EXEMESTANE?

Of the 18 reports, 18 (100.0%) resulted in death, 11 (61.1%) required hospitalization, and 8 (44.4%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXEMESTANE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does EXEMESTANE Cause?

Fatigue (1,122) Malignant neoplasm progression (1,025) Arthralgia (943) Diarrhoea (941) Nausea (913) Neoplasm progression (692) Dyspnoea (673) Malaise (620) Headache (606) Asthenia (597)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which EXEMESTANE Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

EXEMESTANE vs EXENATIDE EXEMESTANE vs EXFORGE EXEMESTANE vs EXJADE EXEMESTANE vs EXTAVIA EXEMESTANE vs EXTRANEAL

Related Pages

EXEMESTANE Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome EXEMESTANE Demographics